Acting on sex and gender in medical innovation is good for business.
Vijayasingham, Lavanya;
Bischof, Evelyne;
Ateghang-Awankem, Bernadette;
Rumaney, Maryam;
Otmani Del Barrio, Mariam;
Cheah, Phaik Yeong;
Ter-Meulen, Ajoke Sobanjo;
Tannenbaum, Cara;
Morgan, Rosemary;
Wolfe, Jeannette;
+1 more...Gender and Covid-19 Research Agenda Setting Initiative;
(2023)
Acting on sex and gender in medical innovation is good for business.
BMJ (Clinical research ed.), 381.
e072242.
ISSN 0959-8138
DOI: https://doi.org/10.1136/bmj-2022-072242
Permanent Identifier
Use this Digital Object Identifier when citing or linking to this resource.
Lavanya Vijayasingham and colleagues argue that as well as improving safety and efficacy, considering sex and gender related factors in medical research can have commercial benefits